LMND vs NNI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Lemonade exhibits critical financial weakness with a Piotroski F-Score of 1/9, indicating severe instability in fundamental health. While the company demonstrates impressive top-line revenue growth of 53.5%, it remains deeply unprofitable with a negative ROE of -29.37% and a negative profit margin. Insider sentiment is strongly bearish, characterized by significant selling from the CEO and CFO with zero buying activity. The current valuation represents a massive premium over book value (P/B 9.36), making the stock a high-risk speculative play despite recent price momentum.
NNI presents a conflicting profile: while the Graham Number ($165.02) suggests defensive value, the Piotroski F-Score of 3/9 indicates weak financial health and deteriorating fundamentals. The stock trades at a low P/E of 12.03 and a very attractive PEG of 0.46, yet it is significantly overpriced relative to its growth-based intrinsic value of $82.46. Negative year-over-year revenue and earnings growth, combined with a bearish technical trend and insider selling, offset the strong liquidity provided by a current ratio of 5.33.
Compare Another Pair
Related Comparisons
LMND vs NNI: Head-to-Head Comparison
This page compares Lemonade, Inc. (LMND) and Nelnet, Inc. (NNI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.